Active Ingredient History

  • Now
Vestipitant (INN) is a drug developed by GlaxoSmithKline which acts as a selective antagonist for the NK1 receptor. It is under development as a potential antiemetic and anxiolytic drug, and as a treatment for tinnitus and insomnia.   Wikipedia

  • SMILES: C[C@@H](N(C)C(=O)N1CCNC[C@@H]1c2ccc(F)cc2C)c3cc(cc(c3)C(F)(F)F)C(F)(F)F
  • Mol. Mass: 491.45
  • ALogP: 5.93
  • ChEMBL Molecule:
More Chemistry
1-piperazinecarboxamide, n-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethyl)-2-(4-fluoro-2- methylphenyl)-n-methyl-, (2s)- | gw597599 | gw-597599 | gw597599b | vestipitant


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue